Intellectual Property, Innovation and Healthcare in Less-Developed Countries
With over half of the world’s poorest people lacking access to life-saving medicines, the relationship between intellectual property rights and healthcare in poor countries has provided emotive discussion over the past few years. To alleviate these appalling conditions, the World Health Organisation (WHO) recently released a Plan of Action that attempts to identify key issues that it thinks should be addressed. According to the WHO, intellectual property rights represent a significant barrier to access.
But should governments invest valuable public health resources into a lengthy discussion about intellectual property rights? Or are there other more relevant issues empower the poor and rid the world of rudimentary illness and disease? Would weakening property protection have an impact on economic growth and wealth creation?
Join the Institute for Policy Innovation and International Policy Network at a briefing featuring international policy experts addressing these and other important questions. Issues to be discussed include:
• The main challenges to health care delivery in poor countries;
• The relationship between IPRs and access to medicines, with evidence from sub-Saharan Africa and Latin America;
• Encouraging value-added innovation and research and development programs around the world.
Silvana Montes de Oca, Embassy of Uruguay and Dr. John Kilama, Founder and President, Global Bioscience Development Institute